InvestorsHub Logo
Followers 8
Posts 812
Boards Moderated 0
Alias Born 07/24/2016

Re: vanderpol post# 60875

Thursday, 01/12/2017 9:44:56 PM

Thursday, January 12, 2017 9:44:56 PM

Post# of 144814
Recently a large portion of patients with a specific disease was able to lobby congress to expedite the medication through. The first article was a success story of patients advocating for the experimental drugs being pushed through quicker, Sarepta is the drug manufacture.

http://www.syracuse.com/news/index.ssf/2016/04/cny_mom_twin_sons_to_testify_before_fda_panel_for_approval_of_experimental_drug.html

https://ww2.kqed.org/stateofhealth/2017/01/02/will-californias-new-right-to-try-law-empower-or-exploit-patients/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News